Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Axonics Inc
(NQ:
AXNX
)
70.37
+0.07 (+0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Axonics Inc
< Previous
1
2
3
Next >
Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council
November 30, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
November 17, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
November 08, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Third Quarter 2021 Financial Results
November 04, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County
October 26, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® to Report Third Quarter 2021 Financial Results on November 4
October 07, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Provides Additional Update on Inter Partes Review Proceedings
September 22, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Partial Decision on Inter Partes Review Proceedings
September 13, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in Upcoming Investor Conferences
August 27, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports Second Quarter 2021 Financial Results
August 05, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors
July 15, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® to Report Second Quarter 2021 Financial Results on August 5, 2021
July 08, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Files PMA Supplement with the FDA for Non-Rechargeable Implantable Sacral Neurostimulator
June 24, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Receives FDA Approval Further Expanding MRI Labeling
May 20, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge Interval
May 18, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
May 14, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Upsize and Pricing of Public Offering of Common Stock
May 11, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Announces Proposed Public Offering of Common Stock
May 11, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® Reports First Quarter 2021 Financial Results
May 06, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® to Participate in the BofA Securities 2021 Virtual Healthcare Conference
April 22, 2021
From
Axonics, Inc.
Via
Business Wire
Axonics® to Report First Quarter 2021 Financial Results on May 6, 2021
April 15, 2021
From
Axonics, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.